BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 2:42:00 PM | Browse: 1050 | Download: 961
Publication Name World Journal of Hepatology
Manuscript ID 9589
Country Brazil
Received
2014-02-20 11:50
Peer-Review Started
2014-02-20 15:55
To Make the First Decision
2014-03-12 16:36
Return for Revision
2014-03-17 17:07
Revised
2014-03-30 01:37
Second Decision
2014-05-16 17:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-16 18:02
Articles in Press
2014-05-23 12:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-01 12:14
Publish the Manuscript Online
2014-07-04 18:01
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Grade 4 febrile neutropenia and Fournier’s Syndrome associated with triple therapy for hepatitis C virus: A case report
Manuscript Source Unsolicited Manuscript
All Author List Kelly Cristhian Lima Oliveira, Emili de Oliveira Bortolon Cardoso, Suzana Carla Pereira de Souza, Flávia Souza Machado, Carlos Eduardo Alves Zangirolami, Alecsandro Moreira, Giovanni Faria Silva and Cássio Vieira de Oliveira
Funding Agency and Grant Number
Corresponding Author Kelly Cristhian Lima Oliveira, MD, Division of Gastroenterology, Department of Internal Medicine, Botucatu School of Medicine, Rubi?o Junior District S/N, 18618-970 S?o Paulo, Brazil. kellycloliveira@hotmail.com
Key Words Hepatitis C; Treatment; Boceprevir; Telaprevir; Adverse events
Core Tip Triple therapy is a recently developed strategy for the treatment of hepatitis C that requires extensive knowledge of adverse effects and drug interactions. It also requires an appreciation of the importance of respecting the guidelines for treatment withdrawal. The case report presented here describes a serious adverse event associated with this new therapy that has not previously been reported in the literature. This finding emphasizes the importance of adequately managing patients according to international clinical protocols, and our study allows for an exchange of experience among experts in the conduct of real-life cases.
Publish Date 2014-07-04 18:01
Citation Oliveira KCL, Cardoso EOB, de Souza SCP, Machado FS, Zangirolami CEA, Moreira A, Silva GF, de Oliveira CV. Grade 4 febrile neutropenia and Fournier’s Syndrome associated with triple therapy for hepatitis C virus: A case report. World J Hepatol 2014; 6(6): 448-452
URL http://www.wjgnet.com/1948-5182/full/v6/i6/448.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i6.448
Full Article (PDF) WJH-6-448.pdf
Full Article (Word) WJH-6-448.doc
Manuscript File 9589-Review.doc
Answering Reviewers 9589-Answering reviewers.pdf
Copyright License Agreement 9589-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9589-Language certificate.pdf
Peer-review Report 9589-Peer review(s).pdf
Scientific Editor Work List 9589-Scientific editor work list.pdf